Baird Medical Investment Holdings Ltd

Baird Medical Investment Holdings Ltd

NNASDAQ:BDMD
0.11
USD
+0.02
(+17.68%)
41.82MMarket Cap
Mar 03Next Earn

Total Valuation

USD

As of December 31, 2025, Baird Medical Investment Holdings Ltd carries a market capitalization of 41.82M, placing it among publicly traded companies globally. Its enterprise value stands at 60.80M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap41.82M
Enterprise Value60.80M

Important Dates

Baird Medical Investment Holdings Ltd's next confirmed earnings release is scheduled for March 3, 2027.

Earnings Date3/3/2027

Share Statistics

As of December 31, 2025, Baird Medical Investment Holdings Ltd has 30.75M shares outstanding.

Shares Outstanding30.75M

Valuation Ratios

These figures are as of December 31, 2025.

PB Ratio1.33
P/TBV Ratio1.34

Financial Position

As of December 31, 2025, Baird Medical Investment Holdings Ltd maintains a current ratio of 1.70, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities.

Current Ratio1.70
Quick Ratio1.32
Debt / Equity61.81

Financial Efficiency

These figures cover the twelve months ended December 31, 2025.

Employee Count144.50

Stock Price Statistics

USD

As of the close on November 16, 2026, Baird Medical Investment Holdings Ltd's stock has declined approximately 91.61% over the past 52 weeks. The 50-day moving average sits at 0.59, while the 200-day moving average is 1.28.

52-Week Price Change-91.61%
50-Day Moving Average0.59
200-Day Moving Average1.28

Balance Sheet

USD

As of December 31, 2025, Baird Medical Investment Holdings Ltd holds 178,321.00 in cash and equivalents against 19.30M in total debt, resulting in a net debt position of 18.98M. Total book value stands at 31.37M, with working capital of 22.61M providing operational flexibility.

Cash & Cash Equivalents178,321.00
Total Debt19.30M
Net Debt18.98M
Equity (Book Value)31.37M
Book Value Per Share1.02
Working Capital22.61M